|
|
|
MIRA INFORM REPORT
|
Report No. : |
493756 |
|
Report Date : |
23.02.2018 |
IDENTIFICATION DETAILS
|
Name : |
ENZENE BIOSCIENCES LIMITED (w.e.f. 22.03.2012) |
|
|
|
|
Formerly Known
As : |
ENZENE
BIOSCIENCES PRIVATE LIMITED |
|
|
|
|
Registered
Office : |
Plot No. 165/1/26, T-Block, MIDC, Bhosari, Pune – 411028, Maharashtra |
|
Tel. No.: |
91-20-30674648 |
|
|
|
|
Country : |
India |
|
|
|
|
Financials (as
on) : |
31.03.2016 |
|
|
|
|
Date of
Incorporation : |
28.08.2006 |
|
|
|
|
Com. Reg. No.: |
11-165610 |
|
|
|
|
Capital
Investment / Paid-up Capital : |
INR 44.810 Million |
|
|
|
|
CIN No.: [Company Identification
No.] |
U24232PN2006PLC165610 |
|
|
|
|
IEC No.: [Import-Export Code No.] |
0707023254 |
|
|
|
|
GSTN : [Goods & Service Tax
Registration No.] |
Not Divulged |
|
|
|
|
TAN No.: [Tax Deduction &
Collection Account No.] |
Not Available |
|
|
|
|
PAN No.: [Permanent Account No.] |
AABCE6662L |
|
|
|
|
Legal Form : |
A Closely Held Public Limited Liability Company |
|
|
|
|
Line of Business
: |
The
company is engaged in carrying out research and development of biological
drugs and drug delivery systems. [Registered Activity] |
|
|
|
|
No. of Employees
: |
Information denied by the management |
RATING & COMMENTS
(Mira Inform has adopted New Rating mechanism w.e.f. 23rd
January 2017)
|
MIRA’s Rating : |
B |
|
Credit Rating |
Explanation |
Rating Comments |
|
B |
Medium Risk |
Business dealings permissible on a regular
monitoring basis |
|
Status : |
Yet to commenced its business operations |
|
|
|
|
Payment Behaviour : |
Unknown |
|
|
|
|
Litigation : |
Clear |
|
|
|
|
Comments : |
Subject is a wholly owned subsidiary of “Alkem Laboratories Limited”
and was incorporated in the year 2006. Mr. Pravin Raman (AGM in Finance and Accounts) has claimed that
company has not yet commence its business operations. However, the satisfactory financial profile of the company is marked
by comfortable networth base along with average debt coverage indicators. Rating takes into consideration equity infused by its promoters. Rating also takes into account of strong financial and managerial
support that company receives from its holding entity backed by its well
experienced management team. Payments are seems to be unknown. In view of aforesaid, the company can be considered for business
dealings with some caution. NOTE: As per the Registrar of Companies date of balance sheet (i.e.
financial filed) is shown as 31.03.2017 but documents related to financial
for the year 31.03.2017 are not available from any sources. |
NOTES:
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
EXTERNAL AGENCY RATING
NOT AVAILABLE
RBI DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter
in the publicly available RBI Defaulters’ list.
EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter
in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of
31-03-2016.
BIFR (Board for Industrial & Financial Reconstruction) LISTING
STATUS
Subject’s name is not listed as a Sick Unit in
the publicly available BIFR (Board for Industrial & Financial
Reconstruction) list as of 23.02.2018
IBBI (Insolvency and Bankruptcy Board of India) LISTING STATUS
Subject’s name is not listed in the publicly
available IBBI (Insolvency and Bankruptcy Board of India) list as of report
date.
INFORMATION DENIED BY
|
Name : |
Mr. Pravin Raman |
|
Designation : |
AGM – Finance and Accounts |
|
Contact No.: |
91-20-30674600 |
|
Date : |
22.02.2018 |
Given number i.e. 91-20-27127845 – does not
exist
LOCATIONS
|
Registered Office : |
Plot No. 165/1/26, T-Block, MIDC, Bhosari, Pune – 411028, Maharashtra,
India |
|
Tel. No.: |
91-20-30674648 / 30674600 |
|
Fax No.: |
Not Available |
|
E-Mail : |
|
|
Website : |
DIRECTORS
AS ON 31.03.2017
|
Name : |
Mr. Himanshu Shashikant Gadgil |
|
Designation : |
Whole-time Director |
|
Address : |
55 - 18 A, Takshashila Apartment, 2, Ashok
Path, Off Law College Road, Pune – 411004, Maharashtra, India |
|
Date of Appointment : |
09.02.2017 |
|
DIN No.: |
07548149 |
|
|
|
|
Name : |
Mr. Basudeo Narayan Singh |
|
Designation : |
Director |
|
Address : |
Budha Colony, Boring Canal Road, Patna –
800001, Bihar, India |
|
Date of Birth/Age : |
20.11.1940 |
|
Date of Appointment : |
20.10.2011 |
|
DIN No.: |
00760310 |
|
|
|
|
Name : |
Mr. Sandeep Singh |
|
Designation : |
Director |
|
Address : |
403 404, Richoux Society JN of St Joseph
Road and Kantw Bandra (West), Mumbai – 400050, Maharashtra, India |
|
Date of Birth/Age : |
23.07.1982 |
|
Date of Appointment : |
20.10.2011 |
|
DIN No.: |
01277984 |
|
|
|
|
Name : |
Mr. Amit Avinash Ghare |
|
Designation : |
Director |
|
Address : |
Flat No-B-406 / 4th Floor, Chembur Heights,
Sindhi Colony, 8th Road, Chembur, Mumbai – 400071, Maharashtra,
India |
|
Date of Birth/Age : |
24.05.1971 |
|
Date of Appointment : |
20.10.2011 |
|
DIN No.: |
05103673 |
|
|
|
|
Name : |
Mr. Ranjal Laxmana Shenoy |
|
Designation : |
Director |
|
Address : |
A-2, Kamdar Park Co-operative Housing
Society Limited, Agar Bazaar, Off Gokhale Road (N), Mumbai – 400028, Maharashtra,
India |
|
Date of Appointment : |
09.02.2017 |
|
DIN No.: |
00074761 |
|
|
|
|
Name : |
Sudha Ravi |
|
Designation : |
Director |
|
Address : |
704/A, 7th Floor, Joanna
Co-operative Housing Society Limited, Manuel Gonsalves Road, Bandra (West),
Mumbai – 400050, Maharashtra, India |
|
Date of Appointment : |
09.02.2017 |
|
DIN No.: |
06764496 |
KEY EXECUTIVES
|
Name : |
Mr. Pravin Raman |
|
Designation : |
AGM – Finance and Accounts |
|
|
|
|
Name : |
Jaya Manohar Nihalani |
|
Designation : |
Company Secretary |
|
Address : |
B-603, Vasant Pride, Thakur Complex, Kandivali (East),
Mumbai – 400101, Maharashtra, India |
|
Date of Appointment : |
09.11.2017 |
|
PAN No.: |
AHRPN2059E |
MAJOR SHAREHOLDERS
AS ON 31.03.2017
|
Names of Shareholders |
No. of Shares |
|
Alkem Laboratories Limited |
11305384 |
|
Rajesh Dubey (Beneficial interest in share is held by Alkem Laboratories Limited) |
1 |
|
Manish Narang (Beneficial interest in share is held by Alkem
Laboratories Limited) |
1 |
|
Pangath Veliyathuvalappil Damodaran (Beneficial interest in
share is held by Alkem Laboratories Limited) |
1 |
|
Amit Avinash Ghare (Beneficial interest in share is held by
Alkem Laboratories Limited) |
1 |
|
Basudeo Narain Singh (Beneficial interest in share is held by
Alkem Laboratories Limited) |
1 |
|
Sandeep Singh (Beneficial interest in share is held by Alkem
Laboratories Limited) |
1 |
|
|
|
|
Total |
11305390 |
Equity Share Break up (Percentage of Total Equity)
AS ON 28.09.2017
|
Category |
Percentage |
|
Promoters [Bodies
corporate] |
100.00 |
|
Total |
100.00 |
BUSINESS DETAILS
|
Line of Business : |
The
company is engaged in carrying out research and development of biological
drugs and drug delivery systems. [Registered Activity] |
||||
|
|
|
||||
|
Products / Services
: |
|
||||
|
|
|
||||
|
Brand Names : |
Not Available |
||||
|
|
|
||||
|
Agencies Held : |
Not Available |
||||
|
|
|
||||
|
Exports : |
Not Divulged |
||||
|
|
|
||||
|
Imports : |
Not Divulged |
||||
|
|
|
||||
|
Terms : |
Not Divulged |
PRODUCTION STATUS – (NOT AVAILABLE)
GENERAL INFORMATION
|
Suppliers : |
|
||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
|
Customers : |
|
||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
|
No. of Employees : |
Information denied by the management |
||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
|
Bankers : |
·
Kotak Mahindra Bank Limited, 27BKC, C 27, G
Block, Bandra Kurla Complex, Bandra (East), Mumbai – 400051, Maharashtra,
India |
||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
|
Facilities : |
|
|
Auditors : |
|
|
Name : |
R.S. Sanghai and Associates Chartered Accountants |
|
Address : |
A 403, Rajkamal Heights, Rajkamal Marg, Dr. S. S. Rao Road, Parel, Mumbai - 400012, Maharashtra, India |
|
PAN No.: |
AAHPS2141R |
|
|
|
|
Memberships : |
Not Available |
|
|
|
|
Collaborators : |
Not Available |
|
|
|
|
Holding company : |
Alkem Laboratories Limited [L00305MH1973PLC174201] |
CAPITAL STRUCTURE
AS ON 28.09.2017
Authorised Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
25000000 |
Equity Shares |
INR 10/- each |
INR 250.000 Million |
|
|
|
|
|
Issued, Subscribed & Paid-up Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
11305390 |
Equity Shares |
INR 10/- each |
INR 113.054 Million |
|
|
|
|
|
AS ON 31.03.2016
Authorised Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
15000000 |
Equity Shares |
INR 10/- each |
INR 150.000 Million |
|
|
|
|
|
Issued, Subscribed & Paid-up Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
4481000 |
Equity Shares |
INR 10/- each |
INR 44.810 Million |
|
|
|
|
|
FINANCIAL DATA
[all figures are
in INR Million]
ABRIDGED
BALANCE SHEET
|
SOURCES OF FUNDS |
31.03.2016 |
31.03.2015 |
31.03.2014 |
|
I.
EQUITY
AND LIABILITIES |
|
|
|
|
(1)Shareholders' Funds |
|
|
|
|
(a) Share Capital |
44.810 |
11.202 |
11.202 |
|
(b) Reserves & Surplus |
110.582 |
(67.404) |
(49.104) |
|
(c) Money
received against share warrants |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
(2) Share Application money pending
allotment |
0.000 |
8.557 |
8.557 |
|
Total
Shareholders’ Funds (1) + (2) |
155.392 |
(47.645) |
(29.345) |
|
|
|
|
|
|
(3)
Non-Current Liabilities |
|
|
|
|
(a) Long-term borrowings |
523.193 |
261.466 |
177.483 |
|
(b) Deferred tax liabilities (Net) |
0.000 |
0.000 |
0.000 |
|
(c) Other long term
liabilities |
0.000 |
0.000 |
0.000 |
|
(d) Long-term
provisions |
0.994 |
1.626 |
0.904 |
|
Total Non-current
Liabilities (3) |
524.187 |
263.092 |
178.387 |
|
|
|
|
|
|
(4)
Current Liabilities |
|
|
|
|
(a) Short
term borrowings |
8.767 |
0.000 |
0.000 |
|
(b) Trade
payables |
64.803 |
5.168 |
8.173 |
|
(c) Other
current liabilities |
9.951 |
5.049 |
2.220 |
|
(d) Short-term
provisions |
0.098 |
0.089 |
0.043 |
|
Total Current
Liabilities (4) |
83.619 |
10.306 |
10.436 |
|
|
|
|
|
|
TOTAL |
763.198 |
225.753 |
159.478 |
|
|
|
|
|
|
II.
ASSETS |
|
|
|
|
(1)
Non-current assets |
|
|
|
|
(a) Fixed
Assets |
|
|
|
|
(i)
Tangible assets |
163.660 |
83.178 |
89.895 |
|
(ii)
Intangible Assets |
0.000 |
0.000 |
0.000 |
|
(iii) Capital
work-in-progress |
1.128 |
0.000 |
0.000 |
|
(iv)
Intangible assets under development |
0.000 |
0.000 |
0.000 |
|
(b) Non-current Investments |
0.000 |
0.000 |
0.000 |
|
(c) Deferred tax assets (net) |
0.000 |
0.000 |
0.000 |
|
(d)
Long-term Loan and Advances |
5.823 |
3.664 |
9.356 |
|
(e) Other
Non-current assets |
0.000 |
0.000 |
0.000 |
|
Total Non-Current
Assets |
170.611 |
86.842 |
99.251 |
|
|
|
|
|
|
(2)
Current assets |
|
|
|
|
(a)
Current investments |
0.000 |
0.000 |
0.000 |
|
(b)
Inventories |
0.000 |
133.765 |
57.054 |
|
(c) Trade
receivables |
0.000 |
0.000 |
0.000 |
|
(d) Cash
and cash equivalents |
518.569 |
1.101 |
0.997 |
|
(e)
Short-term loans and advances |
69.583 |
4.045 |
2.176 |
|
(f) Other
current assets |
4.435 |
0.000 |
0.000 |
|
Total
Current Assets |
592.587 |
138.911 |
60.227 |
|
|
|
|
|
|
TOTAL |
763.198 |
225.753 |
159.478 |
PROFIT
& LOSS ACCOUNT
|
|
PARTICULARS |
31.03.2016 |
31.03.2015 |
31.03.2014 |
||
|
|
SALES |
|
|
|
||
|
|
|
Income |
0.000 |
0.000 |
0.000 |
|
|
|
|
Other Income |
7.396 |
0.719 |
0.052 |
|
|
|
|
TOTAL |
7.396 |
0.719 |
0.052 |
|
|
|
|
|
|
|
||
|
Less |
EXPENSES |
|
|
|
||
|
|
|
Cost of Materials Consumed |
33.494 |
16.730 |
22.920 |
|
|
|
|
Changes in Inventories of finished goods, work-in-progress and
stock-in-trade |
133.765 |
(76.711) |
(57.054) |
|
|
|
|
Employee Benefits Expenses |
29.620 |
26.131 |
17.989 |
|
|
|
|
Other Expenses |
49.125 |
25.859 |
18.115 |
|
|
|
|
TOTAL |
246.004 |
(7.991 |
1.970 |
|
|
|
|
|
|
|
||
|
|
PROFIT/(LOSS)
BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION |
(238.608) |
8.710 |
(1.918) |
||
|
|
|
|
|
|
||
|
Less |
FINANCIAL
EXPENSES |
36.677 |
19.019 |
13.269 |
||
|
|
|
|
|
|
||
|
|
PROFIT/(LOSS)
BEFORE TAX, DEPRECIATION AND AMORTISATION |
(275.285) |
(10.309 |
(15.187) |
||
|
|
|
|
|
|
||
|
Less |
DEPRECIATION/
AMORTISATION |
10.751 |
7.991 |
5.117 |
||
|
|
|
|
|
|
||
|
|
PROFIT/(LOSS)
BEFORE TAX |
(286.036) |
(18.300) |
(20.304) |
||
|
|
|
|
|
|
||
|
Less |
TAX |
0.000 |
0.000 |
0.000 |
||
|
|
|
|
|
|
||
|
|
PROFIT/(LOSS)
AFTER TAX |
(286.036) |
(18.300) |
(20.304) |
||
|
|
|
|
|
|
||
|
|
IMPORTS |
|
|
|
||
|
|
|
Raw Materials |
6.276 |
2.121 |
5.238 |
|
|
|
|
Capital Goods |
79.576 |
0.000 |
22.334 |
|
|
|
TOTAL IMPORTS |
85.852 |
2.121 |
27.572 |
||
|
|
|
|
|
|
||
|
|
Earnings /
(Loss) Per Share (INR) |
(188.03) |
(16.34) |
(18.12) |
||
CURRENT MATURITIES
OF LONG TERM DEBT DETAILS
|
Particulars |
31.03.2016 |
31.03.2015 |
31.03.2014 |
|
Current Maturities of Long term debt |
0.350 |
0.350 |
0.350 |
|
Cash generated from operations |
NA |
NA |
(58.444) |
|
Net cash flows from (used in) operations |
(107.223) |
(64.133) |
NA |
|
Net cash flows from (used in) operating activities |
(107.886) |
(64.133) |
(58.444) |
KEY
RATIOS
EFFICIENCY RATIOS
|
PARTICULARS |
31.03.2016 |
31.03.2015 |
31.03.2014 |
|
Average Collection Days (Sundry
Debtors / Operating Income * 365 Days) |
0.00 |
0.00 |
0.00 |
|
|
|
|
|
|
Account Receivables Turnover (Operating Income / Sundry Debtors) |
0.00 |
0.00 |
0.00 |
|
|
|
|
|
|
Average Payment Days (Sundry Creditors / Purchases * 365 Days) |
706.19 |
112.75 |
130.15 |
|
|
|
|
|
|
Inventory Turnover (Operating Income / Inventories) |
0.00 |
0.07 |
(0.03) |
|
|
|
|
|
|
Asset Turnover (Operating Income / Net Fixed Assets) |
(1.45) |
0.10 |
(0.02) |
LEVERAGE RATIOS
|
PARTICULARS |
31.03.2016 |
31.03.2015 |
31.03.2014 |
|
Debt Ratio ((Borrowing
+ Current Liabilities) / Total Assets) |
0.80 |
1.21 |
1.18 |
|
|
|
|
|
|
Debt Equity Ratio (Total Liability / Networth) |
3.43 |
(5.50) |
(6.06) |
|
|
|
|
|
|
Current Liabilities to Networth (Current Liabilities / Net Worth) |
0.54 |
(0.22) |
(0.36) |
|
|
|
|
|
|
Fixed Assets to Networth (Net Fixed Assets / Networth) |
1.06 |
(1.75) |
(3.06) |
|
|
|
|
|
|
Interest Coverage Ratio (PBIT / Financial Charges) |
(6.51) |
0.46 |
(0.14) |
PROFITABILITY RATIOS
|
PARTICULARS |
|
31.03.2016 |
31.03.2015 |
31.03.2014 |
|
PAT to Total Income ((PAT
/ Total Income) * 100) |
% |
(3867.44) |
(2545.20) |
(39046.15) |
|
|
|
|
|
|
|
Return on Total Assets ((PAT / Total Assets) * 100) |
% |
(37.48) |
(8.11) |
(12.73) |
|
|
|
|
|
|
|
Return on Investment (ROI) ((PAT / Networth) * 100) |
% |
(184.07) |
38.41 |
69.19 |
SOLVENCY RATIOS
|
PARTICULARS |
31.03.2016 |
31.03.2015 |
31.03.2014 |
|
Current Ratio (Current
Assets / Current Liabilities) |
7.09 |
13.48 |
5.77 |
|
|
|
|
|
|
Quick Ratio ((Current Assets – Inventories) / Current
Liabilities) |
7.09 |
0.50 |
0.30 |
|
|
|
|
|
|
G-Score Ratio Financial (Networth / Total Assets) |
0.20 |
(0.21) |
(0.18) |
|
|
|
|
|
|
G-Score Ratio Debt (Debts / Equity Capital) |
11.88 |
23.37 |
15.88 |
|
|
|
|
|
|
G-Score Ratio Liquidity (Total Current Assets / Total Current Liabilities) |
7.09 |
13.48 |
5.77 |
Total
Liability = Short-term Debt + Long-term Debt + Current Maturities of Long-term
debts
FINANCIAL ANALYSIS
[all figures are
in INR Million]
DEBT EQUITY RATIO
|
Particular |
31.03.2014 |
31.03.2015 |
31.03.2016 |
|
|
INR
In Million |
INR
In Million |
INR
In Million |
|
Share Capital |
11.202 |
11.202 |
44.810 |
|
Reserves & Surplus |
(49.104) |
(67.404) |
110.582 |
|
Share Application money pending allotment |
8.557 |
8.557 |
0.000 |
|
Net
worth |
(29.345) |
(47.645) |
155.392 |
|
|
|
|
|
|
Long Term borrowings |
177.483 |
261.466 |
523.193 |
|
Short Term borrowings |
0.000 |
0.000 |
8.767 |
|
Current maturities of long term debt |
0.350 |
0.350 |
0.350 |
|
Total
borrowings |
177.833 |
261.816 |
532.310 |
|
Debt/Equity
ratio |
(6.060) |
(5.495) |
3.426 |
YEAR-ON-YEAR GROWTH
|
Year
on Year Growth |
31.03.2014 |
31.03.2015 |
31.03.2016 |
|
|
INR
In Million |
INR
In Million |
INR
In Million |
|
Total
Income |
0.052 |
0.719 |
7.396 |
|
|
|
1,282.692 |
928.651 |
NET PROFIT MARGIN
|
Net
Profit Margin |
31.03.2014 |
31.03.2015 |
31.03.2016 |
|
|
INR
In Million |
INR
In Million |
INR
In Million |
|
Total
Income |
0.052 |
0.719 |
7.396 |
|
Profit/(Loss) |
(20.304) |
(18.300) |
(286.036) |
|
|
(39046.15%) |
(2545.20%) |
(3867.44%) |
LOCAL AGENCY FURTHER INFORMATION
|
Sr. No. |
Check list by
info agents |
Available in
Report (Yes/No) |
|
1 |
Year of establishment |
Yes |
|
2 |
Constitution of the entity -Incorporation
details |
Yes |
|
3 |
Locality of the entity |
Yes |
|
4 |
Premises details |
No |
|
5 |
Buyer visit details |
-- |
|
6 |
Contact numbers |
Yes |
|
7 |
Name of the person contacted |
Yes |
|
8 |
Designation of contact person |
Yes |
|
9 |
Promoter’s background |
Yes |
|
10 |
Date of Birth of Proprietor / Partners /
Directors |
Yes |
|
11 |
Pan Card No. of Proprietor / Partners |
No |
|
12 |
Voter Id Card No. of Proprietor / Partners |
No |
|
13 |
Type of business |
Yes |
|
14 |
Line of Business |
Yes |
|
15 |
Export/import details (if applicable) |
No |
|
16 |
No. of employees |
No |
|
17 |
Details of sister concerns |
Yes |
|
18 |
Major suppliers |
No |
|
19 |
Major customers |
No |
|
20 |
Banking Details |
Yes |
|
21 |
Banking facility details |
Yes |
|
22 |
Conduct of the banking account |
-- |
|
23 |
Financials, if provided |
Yes |
|
24 |
Capital in the business |
Yes |
|
25 |
Last accounts filed at ROC, if applicable |
No |
|
26 |
Turnover of firm for last three years |
Yes |
|
27 |
Reasons for variation <> 20% |
-- |
|
28 |
Estimation for coming financial year |
No |
|
29 |
Profitability for last three years |
Yes |
|
30 |
Major shareholders, if available |
Yes |
|
31 |
External Agency Rating, if available |
No |
|
32 |
Litigations that the firm/promoter
involved in |
-- |
|
33 |
Market information |
-- |
|
34 |
Payments terms |
No |
|
35 |
Negative Reporting by Auditors in the
Annual Report |
No |
REVIEW OF BUSINESS OPERATIONS AND FUTURE
PROSPECTS [AS ON 2016]:
The Company is engaged in research and development of biosimilars. Alkem Laboratories Limited (Alkem), the Holding Company, is engaged in development, manufacture and sale of pharmaceuticals and nutraceutical products. Alkem conducts its research and development activities in Taloja, Maharashtra. The Company has shifted its operations to Pune, Maharashtra during the year so that it would be conducive to have a vertical integration with Alkems research and development center and to gain advantage through possible sharing of resources. Currently the Company does not have a operational revenue. The directors are optimistic about company’s business and hopeful of generating operating revenue in the years to come.
UNSECURED LOANS:
|
PARTICULARS |
31.03.2016 INR In Million |
31.03.2015 INR In Million |
|
LONG TERM BORROWINGS |
|
|
|
Loans
repayable on demand from others |
521.443 |
0.000 |
|
Loans and advances from directors |
0.000 |
259.366 |
|
|
|
|
|
Total |
521.443 |
259.366 |
INDEX OF CHARGES:
|
S No |
SRN |
Charge Id |
Charge Holder Name |
Date of Creation |
Date of Modification |
Date of Satisfaction |
Amount |
Address |
|
1 |
G48527733 |
100110074 |
AXIS BANK LIMITED |
19/04/2017 |
- |
- |
451400000.0 |
214/215, CITY MALL, 2ND FLOOR, GANESHKHIND ROAD, PUNE MH411007IN |
|
2 |
G41463399 |
100031829 |
KOTAK MAHINDRA BANK LIMITED |
09/03/2016 |
- |
25/03/2017 |
480000000.0 |
27BKC, C 27, G BLOCK BANDRA KURLA COMPLEX, BANDRA (E), MUMBAI MA400051IN |
|
3 |
G06490213 |
10157731 |
DEPARTMENT OF BIOTECHNOLOGY |
11/05/2009 |
28/09/2010 |
03/06/2016 |
3500000.0 |
BLOCK 2, CGO COMPLEX, LODHI ROAD, NEW DELHI DL110003IN |
|
4 |
B40844953 |
10325915 |
CANARA BANK |
24/07/2010 |
- |
29/05/2012 |
7100000.0 |
SPECIALIZED SME PEENYA BRANCH PEENYA INDUSTRIAL AREA BANGALORE KA560058IN |
FIXED ASSETS:
·
Land
·
Building
·
Plant and Machinery
·
Furniture and Fixture
·
Office Equipment
·
Computer
·
Vehicles
CMT REPORT (Corruption, Money Laundering & Terrorism]
The Public Notice information has been collected from various sources
including but not limited to: The Courts,
1] INFORMATION ON
DESIGNATED PARTY
No exist designating subject or any of its beneficial owners,
controlling shareholders or senior officers as terrorist or terrorist
organization or whom notice had been received that all financial transactions
involving their assets have been blocked or convicted, found guilty or against
whom a judgement or order had been entered in a proceedings for violating
money-laundering, anti-corruption or bribery or international economic or
anti-terrorism sanction laws or whose assets were seized, blocked, frozen or
ordered forfeited for violation of money laundering or international
anti-terrorism laws.
2] Court Declaration :
No records exist to suggest that subject is
or was the subject of any formal or informal allegations, prosecutions or other
official proceeding for making any prohibited payments or other improper
payments to government officials for engaging in prohibited transactions or
with designated parties.
3] Asset Declaration :
No records exist to suggest that the property or assets of the subject
are derived from criminal conduct or a prohibited transaction.
4] Record on Financial
Crime :
Charges or conviction
registered against subject: None
5] Records on Violation of
Anti-Corruption Laws :
Charges or
investigation registered against subject: None
6] Records on Int’l
Anti-Money Laundering Laws/Standards :
Charges or
investigation registered against subject: None
7] Criminal Records
No
available information exist that suggest that subject or any of its principals
have been formally charged or convicted by a competent governmental authority
for any financial crime or under any formal investigation by a competent
government authority for any violation of anti-corruption laws or international
anti-money laundering laws or standard.
8] Affiliation with
Government :
No record
exists to suggest that any director or indirect owners, controlling
shareholders, director, officer or employee of the company is a government
official or a family member or close business associate of a Government
official.
9] Compensation Package :
Our market
survey revealed that the amount of compensation sought by the subject is fair
and reasonable and comparable to compensation paid to others for similar
services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE GOVERNANCE
MIRA INFORM as part of its Due Diligence do provide comments on
Corporate Governance to identify management and governance. These factors often
have been predictive and in some cases have created vulnerabilities to credit
deterioration.
Our Governance Assessment focuses principally on the interactions
between a company’s management, its Board of Directors, Shareholders and other
financial stakeholders.
CONTRAVENTION
Subject is not known to have contravened any existing local laws,
regulations or policies that prohibit, restrict or otherwise affect the terms
and conditions that could be included in the agreement with the subject.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
INR |
|
US Dollar |
1 |
INR 65.05 |
|
|
1 |
INR 90.41 |
|
Euro |
1 |
INR 79.83 |
INFORMATION DETAILS
|
Information
Gathered by : |
GYT |
|
|
|
|
Analysis Done by
: |
VAR |
|
|
|
|
Report Prepared
by : |
NKT |
SCORE FACTORS
|
DEMERIT POINTS |
|
|
|
--BANK CHARGES |
YES/NO |
YES |
|
--LITIGATION |
YES/NO |
NO |
|
--OTHER ADVERSE INFORMATION |
YES/NO |
NO |
|
MERIT POINTS |
|
|
|
--SOLE DISTRIBUTORSHIP |
YES/NO |
NO |
|
--EXPORT ACTIVITIES |
YES/NO |
NO |
|
--AFFILIATION |
YES/NO |
YES |
|
--LISTED |
YES/NO |
NO |
|
--OTHER MERIT FACTORS |
YES/NO |
YES |
RATING EXPLANATIONS
|
Credit Rating |
Explanation |
Rating Comments |
|
A++ |
Minimum Risk |
Business dealings permissible with minimum
risk of default |
|
A+ |
Low Risk |
Business dealings permissible with low
risk of default |
|
A |
Acceptable Risk |
Business dealings permissible with
moderate risk of default |
|
B |
Medium Risk |
Business dealings permissible on a regular
monitoring basis |
|
C |
Medium High Risk |
Business dealings permissible preferably
on secured basis |
|
D |
High Risk |
Business dealing not recommended or on
secured terms only |
|
NB |
New Business |
No recommendation can be done due to
business in infancy stage |
|
NT |
No Trace |
No recommendation can be done as the
business is not traceable |
NB is stated where there is insufficient information to facilitate rating. However, it is not to be considered as unfavourable.
This score serves as a reference to assess
SC’s credit risk and to set the amount of credit to be extended. It is
calculated from a composite of weighted scores obtained from each of the major
sections of this report. The assessed factors are as follows:
·
Financial
condition covering various ratios
·
Company
background and operations size
·
Promoters
/ Management background
·
Payment
record
·
Litigation
against the subject
·
Industry
scenario / competitor analysis
·
Supplier
/ Customer / Banker review (wherever available)
This report is issued at
your request without any risk and responsibility on the part of MIRA INFORM
PRIVATE LIMITED (MIPL) or its officials.